330 related articles for article (PubMed ID: 38255650)
1. Chronic Kidney Disease Associated with Ischemic Heart Disease: To What Extent Do Biomarkers Help?
Cepoi MR; Duca ST; Chetran A; Costache AD; Spiridon MR; Afrăsânie I; Leancă SA; Dmour BA; Matei IT; Miftode RS; Miftode L; Prepeliuc CS; Haba MȘC; Bădescu MC; Costache II
Life (Basel); 2023 Dec; 14(1):. PubMed ID: 38255650
[TBL] [Abstract][Full Text] [Related]
2. Renocardiovascular Biomarkers: from the Perspective of Managing Chronic Kidney Disease and Cardiovascular Disease.
Niizuma S; Iwanaga Y; Yahata T; Miyazaki S
Front Cardiovasc Med; 2017; 4():10. PubMed ID: 28321399
[TBL] [Abstract][Full Text] [Related]
3. Association of the biomarkers soluble ST2, galectin-3 and growth-differentiation factor-15 with heart failure and other non-cardiac diseases.
Mueller T; Leitner I; Egger M; Haltmayer M; Dieplinger B
Clin Chim Acta; 2015 May; 445():155-60. PubMed ID: 25850080
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast Growth Factor-23-Klotho Axis in Cardiorenal Syndrome: Mediators and Potential Therapeutic Targets.
Navarro-García JA; González-Lafuente L; Fernández-Velasco M; Ruilope LM; Ruiz-Hurtado G
Front Physiol; 2021; 12():775029. PubMed ID: 34867481
[TBL] [Abstract][Full Text] [Related]
5. Clinical relevance of biomarkers in heart failure and cardiorenal syndrome: the role of natriuretic peptides and troponin.
Palazzuoli A; Masson S; Ronco C; Maisel A
Heart Fail Rev; 2014 Mar; 19(2):267-84. PubMed ID: 23563622
[TBL] [Abstract][Full Text] [Related]
6. [Cardiorenal syndromes].
Késöi I; Sági B; Vas T; Pintér T; Kovács T; Wittmann I; Nagy J
Orv Hetil; 2011 Sep; 152(38):1520-7. PubMed ID: 21896443
[TBL] [Abstract][Full Text] [Related]
7. Utility of Cardiac Biomarkers in the Setting of Kidney Disease.
Savoj J; Becerra B; Kim JK; Fusaro M; Gallieni M; Lombardo D; Lau WL
Nephron; 2019; 141(4):227-235. PubMed ID: 30726855
[TBL] [Abstract][Full Text] [Related]
8. Recombinant
Liu X; Niu Y; Zhang X; Zhang Y; Yu Y; Huang J; Li J; Yu C
Anal Cell Pathol (Amst); 2019; 2019():5853426. PubMed ID: 31309036
[TBL] [Abstract][Full Text] [Related]
9. The Cardiorenal Syndrome: Mechanistic Insights and Prognostication with Soluble Biomarkers.
Seliger S
Curr Cardiol Rep; 2020 Aug; 22(10):114. PubMed ID: 32770361
[TBL] [Abstract][Full Text] [Related]
10. Cardiac markers and cardiovascular disease in chronic kidney disease.
Chen YJ; Chen CC; Er TK
Adv Clin Chem; 2023; 115():63-80. PubMed ID: 37673522
[TBL] [Abstract][Full Text] [Related]
11. Copeptin, Natriuretic Peptides, and Cardiovascular Outcomes in Patients With CKD: The German Chronic Kidney Disease (GCKD) Study.
Schneider MP; Schmid M; Nadal J; Krane V; Saritas T; Busch M; Schultheiss UT; Meiselbach H; Friedrich N; Nauck M; Floege J; Kronenberg F; Wanner C; Eckardt KU;
Kidney Med; 2023 Nov; 5(11):100725. PubMed ID: 37915964
[TBL] [Abstract][Full Text] [Related]
12. Current Use of Cardiac Biomarkers in Various Heart Conditions.
Khan S; Rasool ST
Endocr Metab Immune Disord Drug Targets; 2021; 21(6):980-993. PubMed ID: 32867665
[TBL] [Abstract][Full Text] [Related]
13. Cardiac Biomarkers and Risk of Incident Heart Failure in Chronic Kidney Disease: The CRIC (Chronic Renal Insufficiency Cohort) Study.
Bansal N; Zelnick L; Go A; Anderson A; Christenson R; Deo R; Defilippi C; Lash J; He J; Ky B; Seliger S; Soliman E; Shlipak M; ;
J Am Heart Assoc; 2019 Nov; 8(21):e012336. PubMed ID: 31645163
[TBL] [Abstract][Full Text] [Related]
14. [Cardiorenal syndrome, current understanding].
Ronco F; Ronco C
Recenti Prog Med; 2009 Apr; 100(4):202-13. PubMed ID: 19554920
[TBL] [Abstract][Full Text] [Related]
15. The cardiorenal syndrome.
Ronco C; Chionh CY; Haapio M; Anavekar NS; House A; Bellomo R
Blood Purif; 2009; 27(1):114-26. PubMed ID: 19169027
[TBL] [Abstract][Full Text] [Related]
16. The guanylate cyclase C agonist linaclotide ameliorates the gut-cardio-renal axis in an adenine-induced mouse model of chronic kidney disease.
Nanto-Hara F; Kanemitsu Y; Fukuda S; Kikuchi K; Asaji K; Saigusa D; Iwasaki T; Ho HJ; Mishima E; Suzuki T; Suzuki C; Tsukimi T; Matsuhashi T; Oikawa Y; Akiyama Y; Kure S; Owada Y; Tomioka Y; Soga T; Ito S; Abe T
Nephrol Dial Transplant; 2020 Feb; 35(2):250-264. PubMed ID: 31411705
[TBL] [Abstract][Full Text] [Related]
17. Cardiorenal syndrome: a complex series of combined heart/kidney disorders.
Goh CY; Vizzi G; De Cal M; Ronco C
Contrib Nephrol; 2011; 174():33-45. PubMed ID: 21921607
[TBL] [Abstract][Full Text] [Related]
18. TWEAK-Fn14 as a common pathway in the heart and the kidneys in cardiorenal syndrome.
Poveda J; Vázquez-Sánchez S; Sanz AB; Ortiz A; Ruilope LM; Ruiz-Hurtado G
J Pathol; 2021 May; 254(1):5-19. PubMed ID: 33512736
[TBL] [Abstract][Full Text] [Related]
19. Heart functional and structural compendium of cardiosplenic and cardiorenal networks in acute and chronic heart failure pathology.
Halade GV; Kain V; Ingle KA
Am J Physiol Heart Circ Physiol; 2018 Feb; 314(2):H255-H267. PubMed ID: 29101178
[TBL] [Abstract][Full Text] [Related]
20. Activation of hypoxia-sensing pathways promotes renal ischemic preconditioning following myocardial infarction.
Terker AS; Sasaki K; Arroyo JP; Niu A; Wang S; Fan X; Zhang Y; Nwosisi S; Zhang MZ; Harris RC
Am J Physiol Renal Physiol; 2021 Apr; 320(4):F569-F577. PubMed ID: 33522414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
